Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study for Sugammadex and Neostigmine at Residual Neuromuscular Blockade (T4/T1 = 0.2)

NCT01006720 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT01006720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01006720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study for Sugammadex and Neostigmine at Residual Neuromuscular Blockade (T4/T1 = 0.2)
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
December 31, 2009
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual neuromuscular block (tof-ratio of 0.2)